Showing results (111-120 of 364) with videos related to
Sort By:
Pageof 37
Expert Opinion on Pharmacotherapy|May 14, 2013
Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectivesJulie E Stevens, Karen L Jones, Christopher K Rayner, et al.Expert Review of Gastroenterology & Hepatology|December 10, 2015
Novel insights into the effects of diabetes on gastric motilityChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.Journal of Experimental Psychology. Learning, Memory, and Cognition|July 1, 1988
Elaborative inferences during reading: do they occur on-line?E J O'Brien, D M Shank, J L Myers, et al.Peptides|March 26, 2013
Glucagon-like peptides 1 and 2 in health and disease: a reviewChinmay S Marathe, Christopher K Rayner, Karen L Jones, et al.Diabetes, Obesity & Metabolism|October 27, 2017
Targeting postprandial glycaemia in children with diabetes: Opportunities and challengesMyfanwy C Geyer, Christopher K Rayner, Michael Horowitz, et al.Human Factors|January 2, 2001
The framing of drivers' route choices when travel time information is provided under varying degrees of cognitive loadK V Katsikopoulos, Y Duse-Anthony, D L Fisher, et al.Human Factors|April 1, 1989
Minimizing the time to search visual displays: the role of highlightingD L Fisher, B G Coury, T O Tengs, et al.World Journal of Diabetes|August 5, 2024
Management of gestational diabetes mellitus via nutritional interventions: The relevance of gastric emptyingWei-Kun Huang, Ryan J Jalleh, Christopher K Rayner, et al.The Journal of Clinical Endocrinology and Metabolism|June 5, 2020
Effects of Proximal and Distal Enteral Glucose Infusion on Cardiovascular Response in Health and Type 2 DiabetesXiang Zhang, Karen L Jones, Michael Horowitz, et al.Diabetes, Obesity & Metabolism|January 7, 2017
Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequencesMichael Horowitz, Vanita R Aroda, Jenny Han, et al.Pageof 37